Variant report
Variant | nsv1022362 |
---|---|
Chromosome Location | chr8:51071742-51093985 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:24)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:24 , 50 per page) page:
1
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-C8orf22-14 | chr8:51076059-51076529 | NONHSAT126523 |
2 | lnc-C8orf22-15 | chr8:51085121-51085195 | NONHSAT126524 |
No data |
No data |
Variant related genes | Relation type |
---|---|
SNTG1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs180858570 | chr8:51075209-51075210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550921989 | chr8:51075230-51075231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs568696885 | chr8:51075273-51075274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs186136107 | chr8:51075286-51075287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs78979272 | chr8:51075299-51075300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs529214041 | chr8:51075342-51075343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145846482 | chr8:51075367-51075368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs368693390 | chr8:51075378-51075379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs189917754 | chr8:51075381-51075382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs527703643 | chr8:51075422-51075423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs16914351 | chr8:51075489-51075490 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs34406361 | chr8:51075563-51075564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs375777192 | chr8:51076061-51076062 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs557391727 | chr8:51076077-51076078 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs369832730 | chr8:51076088-51076089 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs543189630 | chr8:51076097-51076098 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs373105932 | chr8:51076160-51076161 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs555570662 | chr8:51076163-51076164 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs573770466 | chr8:51076189-51076190 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs377226479 | chr8:51076190-51076191 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs541290995 | chr8:51076197-51076198 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs559388143 | chr8:51076286-51076287 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs34997857 | chr8:51076290-51076291 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs200686333 | chr8:51076348-51076349 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs73676252 | chr8:51076384-51076385 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs182971769 | chr8:51076387-51076388 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs550385127 | chr8:51076396-51076397 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs568608983 | chr8:51076494-51076495 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs541643124 | chr8:51080877-51080878 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs559931993 | chr8:51081125-51081126 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs142288075 | chr8:51081178-51081179 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs548410810 | chr8:51081197-51081198 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs566327251 | chr8:51081223-51081224 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs534400470 | chr8:51081269-51081270 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs530787131 | chr8:51081281-51081282 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs559282261 | chr8:51081282-51081283 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs571206003 | chr8:51081330-51081331 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs550713665 | chr8:51081353-51081354 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs537420892 | chr8:51081376-51081377 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs146786387 | chr8:51081379-51081380 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs533694397 | chr8:51081854-51081855 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs112234111 | chr8:51081858-51081859 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs146612974 | chr8:51081878-51081879 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs141025116 | chr8:51081944-51081945 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs117281507 | chr8:51081987-51081988 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs115376042 | chr8:51082041-51082042 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs575849923 | chr8:51082412-51082413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs543675429 | chr8:51082424-51082425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs368953744 | chr8:51082434-51082435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs530094924 | chr8:51082459-51082460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:51075200-51075600 | Enhancers | Spleen | Spleen |
2 | chr8:51082400-51084600 | Weak transcription | NH-A | brain |
3 | chr8:51082600-51086400 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
4 | chr8:51084400-51085400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr8:51084600-51086000 | Enhancers | NH-A | brain |
6 | chr8:51085200-51086000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr8:51085200-51086000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr8:51085400-51085600 | ZNF genes & repeats | ES-WA7 Cell Line | embryonic stem cell |
9 | chr8:51085600-51091200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
10 | chr8:51086400-51087000 | ZNF genes & repeats | Ganglion Eminence derived primary cultured neurospheres | brain |
11 | chr8:51087000-51087200 | Strong transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
12 | chr8:51087200-51090600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
13 | chr8:51088400-51088600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
14 | chr8:51089000-51090000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
15 | chr8:51089800-51090600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
16 | chr8:51090000-51090200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
17 | chr8:51090000-51090400 | Enhancers | Brain Germinal Matrix | brain |
18 | chr8:51090000-51090600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
19 | chr8:51090000-51090800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
20 | chr8:51090200-51090400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
21 | chr8:51090200-51090800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
22 | chr8:51090800-51091800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
23 | chr8:51091800-51092200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
24 | chr8:51093400-51094000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
25 | chr8:51093800-51095400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |